Literature DB >> 6972779

Quantitation of red blood cell-bound C3d in normal subjects and random hospitalized patients.

H Chaplin, M Nasongkla, M C Monroe.   

Abstract

A sensitive radiolabelled anti-antiglobulin method was devised and applied to quantitating red blood cell-bound C3d (RBC-C3d) in samples from 174 normal blood donors. C3d was demonstrable on all RBC examined; 98% of values fell over a broad range, with the highest values being approximately 3.5 X the lowest values (equivalent to 50-160 molecules of C3d per cell). RBC-C3d did not correlate with sex or age (over 18-65 years); indirect evidence suggests that values for the paediatric age group will fall in the same normal range. Studies on samples obtained weekly for 10-12 weeks from six adult males and six adult females indicated stable levels of RBC-C3 for individual subjects; i.e. high normals, mid normals and low normals remained in their characteristic range levels over the period of observation. For comparison, RBC-C3d was measured in samples from 313 randomly selected hospitalized adult patients. 33% of the values were above the normal range; 8% were elevated to a level likely to have been detectable by a direct anti-C3d antiglobulin test. The great majority of elevated values occurred in patients not ordinarily considered to have autoimmune conditions. The results provide background for studies of the aetiology and significance of RBC-C3d in health and disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972779     DOI: 10.1111/j.1365-2141.1981.00069.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Complement-regulatory protein expression and activation of complement cascade on erythrocytes from patients with rheumatoid arthritis (RA).

Authors:  M Arora; A Kumar; S N Das; L M Srivastava
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

2.  Further studies of the C3g component of the alpha 2D fragment of human C3.

Authors:  H Chaplin; M C Monroe; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

Review 3.  Complement Dysregulation and Disease: Insights from Contemporary Genetics.

Authors:  M Kathryn Liszewski; Anuja Java; Elizabeth C Schramm; John P Atkinson
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

4.  Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE).

Authors:  H V Marquart; A Svendsen; J M Rasmussen; C H Nielsen; P Junker; S E Svehag; R G Leslie
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

5.  Warm Autoimmune Hemolytic Anemia with a Direct Antiglobulin Test Positive for C3 and Negative for IgG: A Case Study and Analytical Literature Review of Incidence and Severity.

Authors:  Amruth R Palla; Farhad Khimani; Michael D Craig
Journal:  Clin Med Insights Case Rep       Date:  2013-04-02

Review 6.  Autoimmune Hemolysis: A Journey through Time.

Authors:  John Freedman
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

7.  Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen.

Authors:  Amanda Mener; Connie M Arthur; Seema R Patel; Jingchun Liu; Jeanne E Hendrickson; Sean R Stowell
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

8.  Infectious Mononucleosis Causing Acute Liver Failure and Hemolytic Anemia in a Patient with Underlying Hereditary Hemochromatosis.

Authors:  Mark Forsberg; Mark Galan; Joshua Kra
Journal:  Case Rep Oncol       Date:  2020-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.